Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis
Objectives This retrospective cohort study assessed the clinical effectiveness of
nirmatrelvirplus ritonavir (NMV-r) in treating COVID-19 in patients with liver cirrhosis (LC) …
nirmatrelvirplus ritonavir (NMV-r) in treating COVID-19 in patients with liver cirrhosis (LC) …
Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19
The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …
Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19
Objective To investigate the association between nirmatrelvir plus ritonavir (NMV-r) and the
outcomes of non-hospitalized obese patients with coronavirus disease 2019 (COVID-19) …
outcomes of non-hospitalized obese patients with coronavirus disease 2019 (COVID-19) …
Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data
This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV‐r) in treating
patients with coronavirus disease‐2019 (COVID‐19) and substance use disorders (SUDs) …
patients with coronavirus disease‐2019 (COVID‐19) and substance use disorders (SUDs) …
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants
Objectives This study investigated the association between nirmatrelvir plus ritonavir (NMV-
r) or molnupiravir and the outcomes of non-hospitalized high-risk patients with COVID-19 …
r) or molnupiravir and the outcomes of non-hospitalized high-risk patients with COVID-19 …
Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study
Although a novel oral antiviral agent can improve short‐term COVID‐19 outcomes, its effects
on the long‐term outcomes, namely the risk of major adverse cardiovascular events …
on the long‐term outcomes, namely the risk of major adverse cardiovascular events …
The effect of nirmatrelvir‐ritonavir on the long‐term risk of neuropsychiatric sequelae following COVID‐19
The retrospective cohort was conducted to assess the effect of nirmatrelvir‐ritonavir (NMV‐r)
on the long‐term risk of neuropsychiatric sequela following COVID‐19. TriNetX research …
on the long‐term risk of neuropsychiatric sequela following COVID‐19. TriNetX research …
The association between corticosteroids and aspergillosis among COVID-19 patients
We read with great interest the multicenter, observational, retrospective study, which
investigated the impact of dexamethasone on the superinfection in 157 mechanically …
investigated the impact of dexamethasone on the superinfection in 157 mechanically …
Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection
Objectives This study aimed to investigate the association between vitamin D deficiency
(VDD) and post-acute outcomes of severe acute respiratory syndrome coronavirus 2 (SARS …
(VDD) and post-acute outcomes of severe acute respiratory syndrome coronavirus 2 (SARS …
[HTML][HTML] The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer
Backgrounds The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …